Press Releases

MAUI Product Suite Application Notes Enable Superior Hybridization Results Across Multiple Microarray Platforms

May 13, 2009 – Salt Lake City, UT – BioMicro® Systems and its partners have demonstrated compatibility between the MAUI® Product Suite and a wide variety of applications including gene expression, array CGH, miRNA and more. Newly released application notes/protocols are now available at biomicro.com, enabling researchers to expand and optimize their microarray experiments using the MAUI Hybridization System and MAUI Wash System with commercial microarray platforms, including Agilent, Exiqon, Invitrogen, Phalanx, and Roche NimbleGen.

http://www.biomicro.com/maui-applications/

About BioMicro Systems, Inc.
BioMicro Systems, Inc. was founded in 2000 and is based in Salt Lake City, Utah. BioMicro Systems is a private company that serves the life sciences community by developing and marketing biological research products based on its proprietary microfluidic and microarray technologies. In 2003 BioMicro Systems launched the MAUI Hybridization System, a cutting-edge microarray hybridization instrument, designed to alleviate the processing bottleneck encountered during the microarray hybridization process and to help researchers achieve greater sensitivity and more consistent/reproducible results. BioMicro Systems has recently expanded its product portfolio to include the all-new MAUI Wash System and Kreatech labeling kits. BioMicro Systems strives to become the company to provide the standard for achieving superb microarray hybridization results. More company information can be found at www.biomicro.com.

For MAUI Product Suite specifications, product demos, and sales information in the United States and other countries, please contact:
BioMicro Systems, Inc.
Phone: 801-303-1470 or 800-454-1485
E-mail: info@biomicro.com

©2009 BioMicro Systems, Inc. All rights reserved. BioMicro and MAUI are registered trademarks of BioMicro Systems, Inc.